Biotechnology

• Eli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial   - The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill. 
• 'Terrifying': Why U.S. senator in top intel post wants more spying on Chinese companies - Chinese biotech BGI will pass Huawei in scale and threat, says Sen. Mark Warner. 'It's terrifying,' he said at CNBC event, pushing for more corporate spying.
• RFK Jr.'s vaccine panel to vote on changing hepatitis B shot recommendation for babies - The current recommendation for babies to receive a hepatitis B shot within 24 hours of birth is credited with driving down infections in kids by 99%.
• Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site - The announcement comes weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to access.